Pharmacy Report Archives - Page 63 of 139 - Becker's Hospital Review

Can systems compete with CVS, Walgreens? | NYC hospital patients rally over Rx delays | More diabetes drugs in short supply | CDC issues guidance on flu antiviral | FDA to weigh COVID shot reboot

December 19, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Can health systems compete with disruption from CVS, Walgreens? Full story 2. NYC hospital patients rally over EHR outages, prescription delays Full story 3. Eli Lilly's diabetes drugs in short supply:…

AbbVie exits pharma lobbies | Pharmacy worker sentenced for role in meningitis outbreak | Johns Hopkins COO 'quiet quit' years ago | Mass General + 9 other systems seeking pharmacy leaders

December 15, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. AbbVie leaves 2 pharmaceutical lobbies Full story 2. 5th pharmacy worker sentenced for role in deadly meningitis outbreak Full story 3. Vanderbilt Health suspends hospital's chief of staff…

How 'patent thickets' hike prices: Kaiser | Inmate shot, killed in hospital | 1st cancer patient in remission from new gene therapy | Lawmakers press Pfizer on vaccine price | Flu activity by state | 19th drugmaker restricts 340B discounts

December 14, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Biogen 19th drugmaker to shirk access in 340B program, nonprofit says Full story 2. 'Patent thickets' are driving up drug costs, Kaiser leader says Full story 3. 1st patient…

Amoxicillin shortage intensifies | Emory nurses out after viral TikTok of patient 'icks' | Amgen to buy Horizon for $27.8B | Mo. hospital opens specialty pharmacy | The rise of home-delivered scripts

December 12, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Amoxicillin shortage worsens to 44 products, resupply dates pushed to 2023 Full story 2. 2022's priciest healthcare acquisition: Amgen to buy Horizon for $27.8B Full story 3. Emory hospital…

Mark Cuban inks 2nd PBM deal | Ky. hospital to pay $4.3M over diverted drugs | Mayo defends CEO raises | Flu shot 'good match' to circulating strains | 10 systems seeking pharmacy leaders | Vaccine hesitancy's 'nocebo' effect

December 8, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mark Cuban Cost Plus partners with 2nd PBM; hints at insulin market entry Full story 2. FDA hands Pfizer priority review for its RSV vaccine candidate Full story 3. Kentucky hospital…

5 hospital pharmacy leaders envision the future | CMS pitches prior authorization rule | Pfizer v. Moderna: The mRNA patent lawsuits | Leapfrog's 115 top hospitals | Drugmaker didn't plan for Ozempic to go viral | Flu drug supply eases

December 7, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. CMS proposes rule to improve the prior authorization process Full story 2. The future hospital pharmacist Full story 3. Pfizer countersues Moderna in COVID-19 vaccine patent infringement case Full story…

CVS eyes tech for remote pharmacy work | Maine fined Walgreens 15 times for staffing issues | Where XBB is most prevalent | Pharmacy owner sentenced for role in meningitis outbreak that killed 100

December 5, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. CVS tests technology for remote pharmacists to review prescriptions Full story 2. Maine pharmacy board fined Walgreens 15 times for staffing issues Full story 3. President of pharma lobby…

FDA pulls COVID drug amid BQ.1 dominance | 1st fecal transplant therapy approved | Sleeping sickness drug shows promise | Fired MetroHealth CEO paid himself for SDOH work | Mayo Clinic, Kaiser + 8 systems seeking pharmacy leaders

December 1, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA revokes Eli Lilly's COVID-19 drug's authorization Full story 2. Fired MetroHealth CEO factored SDOH work into own bonuses, records show Full story 3. FDA approves 1st fecal transplant…

Civica's 2023 plans | Eisai defends Alzheimer's drug | Tenn. hospital patient dies after defibrillator fire | HHS looks to revise 340B dispute process | Flu admissions up 30% in 1 week | 6 recent payer pharmacy moves

November 30, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Civica's 2023 plans: Full steam ahead on Virginia plant, insulins Full story 2. 'The floodgates opened': Flu hits hospitals Full story 3. HHS proposes 5 fixes to 340B…

Demand for Tamiflu up 100% | BQ.1 could stifle COVID drugs | Fired CEO sues MetroHealth | Ark. hospital files 340B complaint against Novo Nordisk | 'Skinny labels' saved Medicare $1.5B

November 29, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Tamiflu fill rate jumps over 100% Full story 2. Researchers use mRNA technology for potential universal flu vaccine Full story 3. Drugmaker cuts 75% of R&D workforce after FDA…